ask="1.82"
ask_size="3100"
average_daily_volume="246000"
bid="1.80"
bid_size="5900"
book_value="0.34"
change="+0.16"
change_from_200_day_moving_average="0.04"
change_from_50_day_moving_average="0.13"
change_from_52_week_high="-3.31"
change_From_52_week_low="0.68"
change_in_percent="+9.82%"
close="1.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="2.22"
high_52_weeks="5.10"
last_trade_date="1/30/2017"
last_trade_price="1.79"
last_trade_size="212"
last_trade_time="3:59pm"
low="1.76"
low_52_weeks="1.11"
market_capitalization="17.16M"
moving_average_200_day="1.75"
moving_average_50_day="1.66"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.10%"
percent_change_from_50_day_moving_average="+8.04%"
percent_change_from_52_week_high="-64.90%"
percent_change_from_52_week_low="+61.26%"
previous_close="1.63"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.81"
price_per_sales="30.70"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.97"
stock_exchange="NCM"
symbol="EYEG"
volume="4469398"
weeks_range_52="1.11 - 5.10"
